Nine Masts Capital’s Eli Lilly LLY Stock Holding History

Nine Masts Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-450	Closed	-$414K	–	245
2026 Q1	$414K	Buy	+450	New	+$456K	0.06%	93
2025 Q1	–	Sell	-700	Closed	-$540K	–	128
2024 Q4	$540K	Buy	+700	New	+$580K	0.09%	77

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nine Masts Capital's LLY Position: Q2 2026 in Review

Nine Masts Capital sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 450 shares — an estimated $414K sold.

Nine Masts Capital first reported a position in LLY in Q4 2024 and held it in 2 quarters. The position peaked at $540K in Q4 2024. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Nine Masts Capital reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Nine Masts Capital sold 450 Eli Lilly shares in Q2 2026, an estimated $414K.
Nine Masts Capital first reported a position in Eli Lilly in Q4 2024 and held it in 2 quarters.
Nine Masts Capital's Eli Lilly position peaked at $540K in Q4 2024.
4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.